• About 90% of cancers form solid tumors. Solid tumors are lumps of tissue formed by cancer cells growing out of control that can spread to other parts of the body. Approximately 39.5% of men and women will be diagnosed with cancer at some point during their lifetimes. Formulating diagnosis and treatment protocol for a patient requires comprehensive examination results, including complete blood count, biopsy, imaging tests, and molecular genetic tests.
• Molecular genetic testing involves examination at the DNA level. Changes in DNA can lead to alterations in gene function, which in turn may contribute to the development of tumors.
• For people with all types of solid cancer, the AcornOne 808 test uses hybrid capture-based next-generation sequencing (NGS) to read your cancer's DNA. It can help identify what is causing cancer to grow or spread. This information from this testing can be used to help identify how your tumor may respond to treatment. You may also be able to rule therapies out. Your test results can help you and your doctor know which treatments may not work for you—allowing you to focus only on options that may make a difference and avoid unnecessary treatment.

After receiving the AcornOne 808 genetic test report, you can discuss your condition with your doctor.

• A more precise diagnosis of the type of tumor that you have.
• The best treatment choices based on the tumor's genetic profile.
• Which drugs are not likely to work, so you can avoid treatments you don't need, and their side effects.
• Whether you're a good match for one of clinical trials, also known as research studies.
• Information about the likely outcome of your disease (your prognosis).